mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
8e-07 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
9e-07 |